Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 2Smoking Cessation 1Skin Neoplasms 1Prostate Cancer Prevention 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Cardiotoxicity 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Tobacco Use Cessation Devices 11Varenicline 8Surveys and Questionnaires 7Nicotine Replacement Therapy 7Standard of Care 6Motivational Interviewing 4Methods 4Ethanol 4Smoking Devices 3Videotape Recording 2Tobacco Products 2Secondary Prevention 2Preoperative Exercise 2Nicotine Chewing Gum 2Mindfulness 2Hematologic Tests 2Cognitive Behavioral Therapy 2Carbon Monoxide 2Bupropion 2Aspirin 2thiamine triphosphorate 1sulforaphane 1polyphenon E 1cytisine 1Yoga 1Urinalysis 1Transdermal Patch 1Transcranial Direct Current Stimulation 1Tomography, X-Ray Computed 1Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Smoking Cessation × sulforaphane × Clear all
NCT03232138 2024-12-17

Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers

University of Pittsburgh

Phase 2 Completed
43 enrolled 19 charts
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡